Health In Tech Unveils Upgraded eDIYBS Platform at SIIA 2025, Boosting Broker Expansion and Market Presence
Health In Tech's eDIYBS Launch: Health In Tech will showcase its Enhanced Do It Yourself Benefit System (eDIYBS) at the SIIA National Conference, highlighting its capabilities for mid- and large-sized employers and aiming to expand broker relationships.
Efficiency in Quoting and Underwriting: The eDIYBS platform allows brokers to generate quotes for small to mid-sized employers in minutes, significantly reducing traditional quoting times and streamlining workflows for larger employer groups.
Trade with 70% Backtested Accuracy
Analyst Views on HIT
About HIT
About the author

- Investor Summit Participation: Health In Tech will present its AI-driven InsurTech platform at the Market Movers Investor Summit on May 5, 2026, at the historic Bank of New York, which is expected to draw significant investor interest.
- High-Caliber Event Schedule: The summit kicks off on May 4 and includes company presentations, keynote sessions, and one-on-one meetings, aimed at providing a premium networking experience for public and private company executives and investors, enhancing the company's visibility.
- Showcasing Industry Innovation: Health In Tech's platform simplifies health insurance processes and offers a self-service health insurance marketplace, helping insurers and brokers improve efficiency, which is likely to attract more clients and partners.
- Market Potential: As the demand for automation and streamlined processes in the health insurance sector grows, Health In Tech's innovative solutions are poised to significantly increase market share and revenue in the coming years.
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding to support the next phase of platform development.
- Support for Strategic Growth: CEO Tim Johnson stated that the additional capital will be allocated to key technology initiatives, enabling the company to launch new product capabilities actively requested by clients, thereby enhancing customer engagement and supporting sustainable revenue growth.
- Increased Market Visibility: CFO Julia Qian highlighted that the transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby strengthening its competitive position in the industry.
- Compliance Statement: The securities are being offered under Section 4(a)(2) of the Securities Act of 1933 and have not been registered in the U.S., requiring investors to be aware of registration requirements and legal restrictions to ensure compliance.
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding for the company's technology development.
- Use of Proceeds: The company intends to allocate the net proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, thereby enhancing market competitiveness and addressing client demands to drive sustainable revenue growth.
- Investor Base Expansion: This transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby increasing financial flexibility.
- Strategic Development: CEO Tim Johnson stated that this financing will accelerate the next phase of platform development, further deepen customer engagement, and support the company's long-term growth strategy.
- Financing Amount: Health In Tech successfully closed a PIPE financing of approximately $7 million, issuing 5,600,000 shares of common stock at $1.25 per share, which will provide essential funding for the company's platform development and enhance its competitive position in the market.
- Use of Proceeds: The company intends to allocate the proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, which will help deepen customer engagement and drive sustainable revenue growth.
- Investor Base Enhancement: This transaction introduces new long-term institutional investors to the shareholder base, which is expected to enhance market visibility and support the company's broader capital markets strategy while providing the flexibility to continue investing in technology and growth initiatives.
- Compliance Statement: The financing is conducted under Section 4(a)(2) of the Securities Act of 1933, and the securities have not been registered in the U.S., indicating that a resale registration statement may be required in the future to comply with securities laws.

Health in Tech: The health technology sector is experiencing significant financial activity, with gross proceeds from a recent PIPE expected to reach approximately $7 million.
PIPE Financing: The anticipated PIPE (Private Investment in Public Equity) filing indicates a strong interest in health tech investments, reflecting confidence in the sector's growth potential.









